MedPath

BIBAG

BIBAG

Approved
DIN Number

02487756

Drug Class

Human

Market Date

Jan 30, 2020

Company
HC

fresenius medical care canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02487756
AIG Number0104153026
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationHaemodialysis
AHFS Classification40:34.00*
Health Canada Classification

ACTIVE INGREDIENTS (1)

SODIUM BICARBONATEActive
Strength: 900 G / BAG
Monograph: SODIUM BICARBONATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.